Compositions and methods for the treatment of chronic diseases and inflammatory disorders
OwnerMahesh Kandulainventor
Life of this patent
Estimating the term…
Loading patent…
OwnerMahesh Kandulainventor
Estimating the term…
The invention relates to the compounds of formula I or its pharmaceutical acceptable salts, as well as polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising an effective amount of compounds of formula I, and methods for the treatment of chronic diseases and inflammatory disorders may be formulated for oral, buccal, rectal, topical, transdermal, transmucosal, intravenous, parenteral administration, syrup, or injection. Such compositions may be used to treatment of intermittent claudication, obstructed arteries in the limbs, vascular dementia, Peyronie's disease, neuropathic injuries, sickle cell disease, nausea and headaches in the mountains (altitude sickness), acute alcoholic and non-alcoholic steatohepatitis, alcoholic liver disease, fibrotic lesions induced by radiation therapy for cancer, cytokine release syndrome, endometriosis, venous disease, inflammation, cancer, stroke, thrombosis, sepsis, gangrene, infection, type 1 diabetes, type 2 diabetes, pancreatic beta cell degeneration, beta cell dysfunction, respiratory diseases, rheumatoid arthritis, arthritis, osteoarthritis and vascular disease.
A Compound of formula I:
A pharmaceutical composition comprising a molecular conjugate of pentoxifylline and R-Lipoic acid.
A pharmaceutical composition comprising a molecular conjugate of pentoxifylline and eicosapentaenoic acid.
A pharmaceutical composition comprising a molecular conjugate of pentoxifylline and docosahexaenoic acid.
A pharmaceutical composition comprising a molecular conjugate of pentoxifylline and salsalate.
A pharmaceutical composition comprising a molecular conjugate of pentoxifylline and mesalamine.
A pharmaceutical composition comprising a molecular conjugate of pentoxifylline and fumaric acid.
A pharmaceutical composition comprising a molecular conjugate of pentoxifylline and pyridoxamine.
A pharmaceutical composition comprising a molecular conjugate of pentoxifylline and cysteamine.
A pharmaceutical composition comprising a molecular conjugate of pentoxifylline and arhalofenate.
A pharmaceutical composition comprising a molecular conjugate of lisofylline and R-Lipoic acid.
A pharmaceutical composition comprising a molecular conjugate of lisofylline and eicosapentaenoic acid.
A pharmaceutical composition comprising a molecular conjugate of lisofylline and docosahexaenoic acid.
A pharmaceutical composition comprising a molecular conjugate of lisofylline and salsalate.
A pharmaceutical composition comprising a molecular conjugate of lisofylline and mesalamine.
A pharmaceutical composition comprising a molecular conjugate of lisofylline and fumaric acid.
A pharmaceutical composition comprising a mol molecular conjugate of lisofylline and pyridoxamine.
A pharmaceutical composition comprising a molecular conjugate of lisofylline and cysteamine.
A pharmaceutical composition comprising a molecular conjugate of lisofylline and arhalofeante.
Dependencies are inferred from the claim text.